Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis

Published on Jun 24, 2013in United European gastroenterology journal3.549
· DOI :10.1177/2050640613495196
Tsukasa Ikeura19
Estimated H-index: 19
(Kansai Medical University),
Riccardo Manfredi24
Estimated H-index: 24
(University of Verona)
+ 10 AuthorsLuca Frulloni58
Estimated H-index: 58
(University of Verona)
Background: International consensus diagnostic criteria (ICDC) have been proposed to classify autoimmune pancreatitis (AIP) in type 1, type 2, or not otherwise specified. Objective: Aim was to apply the ICDC to an Italian series of patients to evaluate the incidence and clinical profiles among different subtypes of AIP. Methods: we re-evaluated and classified 92 patients diagnosed by Verona criteria, according to the ICDC. Results: Out of 92 patients, 59 (64%) were diagnosed as type 1, 17 (18%) as type 2, and 15 (16%) as not otherwise specified according to the ICDC. A significant difference between type 1 and type 2 were found for age (54.5 � 14.5 vs. 34.4 � 13.9 respectively; p <0.0001), male sex (76 vs. 47%; p ¼0.007), jaundice (66 vs. 18%; p ¼0.002) and acute pancreatitis (9 vs. 47%; p <0.0001), elevated serum IgG4 levels (85 vs. 7%; p <0.0001), inflammatory bowel disease (8 vs. 82%; <0.0001), and relapse of the disease (34 vs. 6%; p ¼0.058). Imaging and response to steroids in the not-otherwise-specified group were similar to type 1 and 2. Conclusions: Type 1 has a different clinical profile from type 2 autoimmune pancreatitis. The not-otherwise-specified group has peculiar clinical features which are shared both with type 1 or type 2 groups.
📖 Papers frequently viewed together
14 Authors (Tooru Shimosegawa, ..., Lizhi Zhang)
948 Citations
140 Citations
172 Citations
#1Phil A. Hart (Mayo Clinic)H-Index: 29
#2Mark Topazian (Mayo Clinic)H-Index: 65
Last. Suresh T. Chari (Mayo Clinic)H-Index: 103
view all 14 authors...
Background There is a paucity of data on long-term management of type 1 autoimmune pancreatitis (AIP), a relapsing steroid-responsive disorder. Objective We describe our experience with treatment of relapses and maintenance of remission using steroid-sparing immunomodulators (IMs) and induction of remission using rituximab (RTX). Methods We obtained details of disease relapse and treatment in 116 type 1 AIP patients from clinic visits, medical records and telephone interviews. We compared relaps...
254 CitationsSource
#1Gokulakrishnan Balasubramanian (Mayo Clinic)H-Index: 8
#2Aravind Sugumar (Mayo Clinic)H-Index: 17
Last. Suresh T. Chari (Mayo Clinic)H-Index: 103
view all 13 authors...
Abstract Background Autoimmune pancreatitis (AIP) has been classified into type 1 and type 2 subtypes. Serum immunoglobulin G4 (IgG4) elevation characterizes type 1 AIP. Type 2 AIP and a subset of type 1 AIP are seronegative, i.e., have normal serum IgG4 levels. Aim We compared the profiles of the three subsets of AIP to identify the unique characteristics of seronegative type 1 AIP and type 2 AIP. Methods We compared the clinical profiles of 69 seropositive type 1 AIP patients, 21 seronegative ...
16 CitationsSource
#1Sönke Detlefsen (OUH: Odense University Hospital)H-Index: 21
#2Giuseppe Zamboni (University of Verona)H-Index: 81
Last. Günter Klöppel (TUM: Technische Universität München)H-Index: 38
view all 9 authors...
Abstract Background At the recent consensus conference on autoimmune pancreatitis (AIP) in Honolulu, we presented preliminary data from our study of surgically treated AIP patients. Our data strongly supported the separation of AIP into type 1 and type 2. Our study is based on a total of 114 surgically treated European AIP patients. Our aims were to elucidate serum IgG4 elevation, other organ involvement, relapse of disease, steroid treatment and diabetes after surgery in 114 surgically treated ...
62 CitationsSource
#1Tae Jun Song (Inje University)H-Index: 7
#1Tae Jun Song (Inje University)H-Index: 27
Last. Eunsil Yu (UOU: University of Ulsan)H-Index: 32
view all 9 authors...
Background and Aim: Type 2 autoimmune pancreatitis (AIP) has been reported mainly in Western countries and is thought to be very rare in Asia. The aim of this study was to compare the prevalence, clinical profiles, detailed radiological findings, and steroid responsiveness between type 1 and type 2 AIP in Korea. Methods: From 120 patients diagnosed with AIP between January 2003 and August 2010, 52 patients with histologically confirmed type 1 (n = 37) or type 2 (n = 15) AIP were included. Result...
49 CitationsSource
#1Kenichiro ImaiH-Index: 26
Last. Hiroyuki OnoH-Index: 30
view all 6 authors...
Abstract Backgrounds The effectiveness of endoscopic ultrasonography-guided fine-needle aspiration (EUS-FNA) has not been fully evaluated in the diagnosis of autoimmune pancreatitis (AIP). Aim To evaluate the effectiveness of EUS-FNA using 22-gauge needles in the diagnosis of AIP. Methods EUS-FNA was examined in 85 patients with pancreatic mass, including 64 patients with pancreatic cancer and 21 patients with AIP. We investigated ability of EUS-FNA using 22-gauge needle for the differential dia...
55 CitationsSource
#1Luca Frulloni (University of Verona)H-Index: 58
#2Claudio Lunardi (University of Verona)H-Index: 39
Autoimmune pancreatitis (AIP) is a well-defined clinical entity athologically different from all the other forms of chronic panreatitis. Since its first description, the concept of the disease has reatly changed over time. On the basis of pathological findings, the disease has been ecently classified in type 1 AIP (also called Lympho-Plasmacytic clerosing Pancreatitis – LPSP), and type 2 AIP (also called Idiopathic uct-centric Chronic Pancreatitis – IDCP), as reported by Matsubyashi et al. [1]. ...
22 CitationsSource
#2Hiroaki SawaiH-Index: 9
Last. Hiroyuki OnoH-Index: 30
view all 11 authors...
a b s t r a c t Background: Autoimmune pancreatitis is categorized as an IgG4-related autoimmune disease, mostly associated with serological alterations, however characteristics of autoimmune pancreatitis based on serum markers have not been fully evaluated. Methods: We evaluated demographics, symptoms, imaging and therapeutic outcome in 27 cases of autoimmune pancreatitis stratified by serum IgG4 level. Results: Twenty patients (74%) had elevated serum IgG4 and 7 (26%) had normal IgG4 levels. C...
44 CitationsSource
#1Riccardo Manfredi (University of Verona)H-Index: 51
#2Luca FrulloniH-Index: 58
Last. Roberto Pozzi MucelliH-Index: 38
view all 6 authors...
MR imaging can depict pancreatic abnormalities suggestive of autoimmune pancreatitis at diagnosis and the remission of these abnormalities after steroid therapy, and the bile ducts and the kidneys also may be involved and should be assessed; during follow-up, the risk of recurrence increases with time.
72 CitationsSource
#1Terumi Kamisawa (Tokyo Metropolitan Komagome Hospital)H-Index: 77
#2Suresh T. ChariH-Index: 103
Last. Vay Liang W. Go (UCLA: University of California, Los Angeles)H-Index: 93
view all 22 authors...
: The objective of this study was to clarify the clinical and pathophysiological characteristics of autoimmune pancreatitis (AIP) and its subtypes (lymphoplasmacytic sclerosing pancreatitis [LPSP] and idiopathic duct-centric pancreatitis [IDCP]) seen around the world.: An international multicenter survey of AIP was conducted in 15 institutes from 8 countries. We compared clinical and pathologic profiles of AIP (n = 731) and the clinical profiles of LPSP (n = 204) and IDCP (n = 64) patients.: Pat...
187 CitationsSource
#1Luca Frulloni (University of Verona)H-Index: 58
#2Antonio AmodioH-Index: 13
Last. Italo VantiniH-Index: 36
view all 4 authors...
Autoimmune pancreatitis is a disease characterized by specific pathological features, different from those of other forms of pancreatitis, that responds dramatically to steroid therapy. The pancreatic parenchyma may be diffusely or focally involved with the possibility of a low-density mass being present at imaging, mimicking pancreatic cancer. Clinically, the most relevant problems lie in the diagnosis of autoimmune pancreatitis and in distinguishing autoimmune pancreatitis from pancreatic canc...
33 CitationsSource
Cited By32
#1Yoshiharu Masaki (Sapporo Medical University)H-Index: 7
#2Hiroshi Nakase (Sapporo Medical University)H-Index: 48
Last. Yuzo Kodama (Kobe University)H-Index: 35
view all 0 authors...
The effectiveness of azathioprine (AZA) in preventing relapse and maintaining autoimmune pancreatitis (AIP) remission has been reported; however, most of these studies are case series with no randomized control trials available in the literature. Therefore, this study performed a systematic review and meta-analysis of the existing literature on this subject to determine the clinical efficacy of AZA as maintenance therapy for AIP patients. A systematic search was performed to identify studies on ...
#1Teresa Marzia Rogger (University of Verona)
#2Giulia De MarchiH-Index: 6
Last. Rachele CiccocioppoH-Index: 30
view all 11 authors...
OBJECTIVES Type 1 autoimmune pancreatitis (AIP) is a manifestation of immunoglobulin G4-related diseases (IgG4-RD). To evaluate the activity of the disease, the IgG4-RD responder index (RI) has been created. This study evaluated the IgG4-RD RI as prognostic factor of 1-year disease relapse. METHODS Patients diagnosed with type 1 AIP between January 2012 and December 2016, with available magnetic resonance imaging and IgG4 dosage, were enrolled. Immunoglobulin G4-RD RI was calculated at baseline ...
#1Nicolò de PretisH-Index: 8
#2Antonio AmodioH-Index: 13
Last. Luca FrulloniH-Index: 11
view all 3 authors...
#1Seung Bae Yoon (Catholic University of Korea)H-Index: 10
#2Sung-Hoon Moon (Hallym University)H-Index: 8
Last. Myung-Hwan Kim (UOU: University of Ulsan)H-Index: 89
view all 6 authors...
Abstract null null Background null The indications for maintenance glucocorticoid therapy (MGT) and its duration after initial remission of type 1 autoimmune pancreatitis (AIP) remain controversial. In contrast to the Japanese treatment protocol, the Mayo protocol does not recommend MGT after initial remission. This study aimed to evaluate the relapse rate in patients with type 1 AIP according to the duration of glucocorticoid therapy. null null null Methods null We conducted a systematic litera...
1 CitationsSource
PURPOSE OF REVIEW Type 2 autoimmune pancreatitis (AIP) is a rare inflammatory disease of the pancreas. Very few data have been published on this particular subtype, which differs from the 'classical' IgG4-related type 1 AIP in terms of pathological features, epidemiology and risk of relapse. The aim of the current review is to summarize the available literature, suggesting a diagnostic and therapeutic approach to this disease. RECENT FINDINGS Based on the International Consensus Diagnostic Crite...
2 CitationsSource
#1Robbie R. Goodman (U of T: University of Toronto)H-Index: 1
#2Madelaine K. Jong (U of T: University of Toronto)H-Index: 1
Last. John E. Davies (U of T: University of Toronto)H-Index: 55
view all 3 authors...
Abstract To date only small animal models have been employed to assess the effect of mesenchymal stromal cell (MSC) therapy on acute pancreatitis (AP), the most common cause of hospitalization for gastrointestinal diseases worldwide. We outline the challenges inherent in the small animal models of AP. We also point to specific benefits afforded by the adoption of larger animal models. The potential for MSC therapeutics in the treatment of AP was recognized over a decade ago. With sharper focus o...
5 CitationsSource
#1Mario Pelaez-Luna (UNAM: National Autonomous University of Mexico)H-Index: 17
Last. L.F. Uscanga-DomínguezH-Index: 7
view all 4 authors...
Autoimmune pancreatitis has received considerable attention, especially due to the marked effect of corticosteroid therapy on its clinical course. Knowledge, especially regarding type 1 autoimmune pancreatitis, has significantly increased over the last decades, and despite significant differences in pathophysiology and outcomes, both type 1 and 2 autoimmune pancreatitis are still considered different types of the same disease. Some have proposed a different nomenclature reflecting these differen...
#1Luca Barresi (ISMETT)H-Index: 22
#2Matteo Tacelli (ISMETT)H-Index: 5
Last. EndoscopistsH-Index: 1
view all 29 authors...
BackgroundAutoimmune pancreatitis (AIP) is a rare, and relatively new, form of chronic pancreatitis. The management of AIP can vary considerably among different centres in daily clinical practice.O...
5 CitationsSource
#1Nicolò de Pretis (University of Verona)H-Index: 8
#2Filippo Vieceli (University of Verona)H-Index: 3
Last. Luca Frulloni (University of Verona)H-Index: 58
view all 6 authors...
Abstract Background Autoimmune pancreatitis (AIP) is a well-recognized fibroinflammatory disease of the pancreas. Despite the significant number of studies published on AIP type 1 and 2, no studies have been focused on AIP type not otherwise specified (NOS) and therefore very little is known about clinical features and long-term outcomes of these patients. The aim of this study was to investigate clinical and radiological features of AIP type NOS-patients. Methods Patients classified as AIP type...
4 CitationsSource
#1Matteo Tacelli (University of Palermo)H-Index: 5
#2Ciro Celsa (University of Palermo)H-Index: 10
Last. Calogero Cammà (University of Palermo)H-Index: 76
view all 9 authors...
Background & Aims Risk for relapse after induction of remission with steroid therapy has been studied extensively in patients with autoimmune pancreatitis (AIP), but findings have been equivocal. We performed a systematic review and meta-analysis to estimate the relapse rate of AIP after initial remission after steroid treatment and to identify factors associated with relapse. Methods Three reviewers searched MEDLINE, SCOPUS, and EMBASE until July 2018 to identify studies on rate of relapse of A...
11 CitationsSource